Yingda Xu

Xuzhou Medical College — China

Medicine · Health Sciences

26h-index4.3kcitations49works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(24), Protein purification and stability(19), Viral Infectious Diseases and Gene Expression in Insects(7), Mass Spectrometry Techniques and Applications(5), Cerebrovascular and Carotid Artery Diseases(5)

Publications49 total

Risk factors of acute ischemic stroke and the role of angiotensin I in predicting prognosis of patients undergoing endovascular thrombectomy
Frontiers in Endocrinology·2024· 1 citedOpen Access
Abstract 5083: Discovery of an asymmetric IgG-like bispecific ADC targeting EGFR/HER3
Cancer Research·2024
Research on Combating Terrorism on Protecting the Right of Existence Dimension
Legal Science in China and Russia·2023Open Access
Abstract 5675: Discovery and development of an asymmetric IgG-like bispecific antibody targeting EGFR and c-MET, engineered through H-H and H-L chain charge-based heterodimerization
Cancer Research·2023
Application of LV's distribution on the parameter estimation of multicomponent radar emitter signals
IET conference proceedings.·2023· 2 cited
DavarOCR: A Toolbox for OCR and Multi-Modal Document Understanding
Proceedings of the 30th ACM International Conference on Multimedia·2022· 5 cited
DavarOCR: A Toolbox for OCR and Multi-Modal Document Understanding
arXiv (Cornell University)·2022Open Access
Abstract 5527: A novel fully human anti-TIGIT and PVRIG bispecific antibody that elicits potent anti-tumor efficacy in pre-clinical studies
Cancer Research·2022
Abstract 5525: An Fc-competent bispecific antibody targeting PD-L1 and TIGIT induces strong immune responses and potent anti-tumor efficacy
Cancer Research·2022· 3 cited
895 Discovery of a safer 4–1BB agonist by targeting a membrane-proximal epitope combined with bispecific-mediated cross-bridging
Regular and Young Investigator Award Abstracts·2021· 1 citedOpen Access
Deep Feature Fusion Based Dual Branch Network for X-ray Security Inspection Image Classification
Applied Sciences·2021· 6 citedOpen Access
Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer
Journal for ImmunoTherapy of Cancer·2021· 43 citedOpen Access
A novel biparatopic antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
2020· 2 cited
The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies
Engineering Reports·2020· 10 citedOpen Access
Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors
PLoS ONE·2020· 38 citedOpen Access
The role of carotid stenosis ultrasound scale in the prediction of ischemic stroke
Neurological Sciences·2020· 16 citedOpen Access
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
mAbs·2020· 34 citedOpen Access
Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability
Cell Reports·2019· 98 citedOpen Access
Structure, heterogeneity and developability assessment of therapeutic antibodies
mAbs·2018· 254 citedOpen Access
Deamidation and isomerization liability analysis of 131 clinical-stage antibodies
mAbs·2018· 140 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Tingwan Sun(12), Heather Lynaugh(11), Tushar Jain(10), Isabelle Caffry(10), Maximiliano Vásquez(10), Yao Yu(8), Michael E. Brown(8), Joanne Sun(8), Patricia A. Estep(7), Yingming Zhao(6), Yuan Cao(6), Irina Burnina(6), Chao Wang(6), Shaogang Peng(6), Xiaoniu Miao(6), Yongan Sun(6), K. Dane Wittrup(5), Asparouh Lilov(5), Andy Tsun(5), Mingli He(5)